Price Chart

Profile

Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
URL https://www.medpace.com
Investor Relations URL https://investor.medpace.com/
HQ State/Province Ohio
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Growth
Next Earnings Release Apr. 24, 2024 (est.)
Last Earnings Release Feb. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
URL https://www.medpace.com
Investor Relations URL https://investor.medpace.com/
HQ State/Province Ohio
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Growth
Next Earnings Release Apr. 24, 2024 (est.)
Last Earnings Release Feb. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A